Cargando…
P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429459/ http://dx.doi.org/10.1097/01.HS9.0000968876.25462.61 |
| _version_ | 1785090718573789184 |
|---|---|
| author | Koenig, Kristin Miguel Bergua Burgues, Juan Montesinos, Pau Walker, Alison Bixby, Dale Burke, Patrick Daver, Naval Konopleva, Marina Anthony, Stephen Tan, Fenlai Chen, Yi Chen, Yu Shen, Yue Curran, Emily |
| author_facet | Koenig, Kristin Miguel Bergua Burgues, Juan Montesinos, Pau Walker, Alison Bixby, Dale Burke, Patrick Daver, Naval Konopleva, Marina Anthony, Stephen Tan, Fenlai Chen, Yi Chen, Yu Shen, Yue Curran, Emily |
| author_sort | Koenig, Kristin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429459 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294592023-08-17 P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA Koenig, Kristin Miguel Bergua Burgues, Juan Montesinos, Pau Walker, Alison Bixby, Dale Burke, Patrick Daver, Naval Konopleva, Marina Anthony, Stephen Tan, Fenlai Chen, Yi Chen, Yu Shen, Yue Curran, Emily Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429459/ http://dx.doi.org/10.1097/01.HS9.0000968876.25462.61 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Koenig, Kristin Miguel Bergua Burgues, Juan Montesinos, Pau Walker, Alison Bixby, Dale Burke, Patrick Daver, Naval Konopleva, Marina Anthony, Stephen Tan, Fenlai Chen, Yi Chen, Yu Shen, Yue Curran, Emily P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA |
| title | P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA |
| title_full | P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA |
| title_fullStr | P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA |
| title_full_unstemmed | P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA |
| title_short | P492: SAFETY AND EFFICACY OF LP-108 AS MONOTHERAPY AND COMBINED WITH AZACITIDINE IN PATIENTS WITH RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA |
| title_sort | p492: safety and efficacy of lp-108 as monotherapy and combined with azacitidine in patients with relapsed/refractory myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429459/ http://dx.doi.org/10.1097/01.HS9.0000968876.25462.61 |
| work_keys_str_mv | AT koenigkristin p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT miguelberguaburguesjuan p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT montesinospau p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT walkeralison p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT bixbydale p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT burkepatrick p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT davernaval p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT konoplevamarina p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT anthonystephen p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT tanfenlai p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT chenyi p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT chenyu p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT shenyue p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia AT curranemily p492safetyandefficacyoflp108asmonotherapyandcombinedwithazacitidineinpatientswithrelapsedrefractorymyelodysplasticsyndromeschronicmyelomonocyticleukemiaoracutemyeloidleukemia |